Implementation Of A Treat-to-target Remission Strategy For Rheumatoid Arthritis In Australian Public And Private Rheumatology Clinics
Funder
National Health and Medical Research Council
Funding Amount
$178,157.00
Summary
Rheumatoid arthritis (RA) is a common and incurable inflammatory joint disease affecting 2% of Australians. RA is associated with significant pain, disability, loss of work capacity and reduced life expectancy. Research has shown that 'treating to a target' for the goal of remission significantly improves outcomes for people living with RA. This TRIP fellowship will assess the barriers to clinicians and people living with RA managing the disease in a targeted way and develop a package to assist.
Improving Translation Of Evidence Into Practice For Musculoskeletal Conditions
Funder
National Health and Medical Research Council
Funding Amount
$948,684.00
Summary
Musculoskeletal conditions place a huge burden on the world’s population. Yet current trials in this field may not reflect priorities based upon this burden and few trials address well-recognised evidence-practice gaps. My fellowship will aim to transform the current ad hoc approach to Australian musculoskeletal clinical trials. It will identify the most critical unanswered questions, formulate a national research agenda, and identify best methods for optimising uptake of findings into practice.